Error loading player: No playable sources found
73565
Session III: Mass Spectrometry in Gene and Cell Therapy
Date
September 7, 2023
This product is not available for individual purchase, but it is available as part of the following products:
Session Speakers:
Applications of Mass Spectrometry in CRISPR based Cell Therapy and Gene Editing Therapy
Bo Yan, Beam Therapeutics
LC-MS/MS as a Potency Assay for mRNA Vaccines
Aline Dörrbaum, BioNTech SE
Proteomic Approaches for Characterization of Live Biotherapeutic Escherichia coli Nissle Products from Fermentation to Therapeutic Activity
Steven Bruckbauer, Synlogic Operating Company
Applications of Mass Spectrometry in CRISPR based Cell Therapy and Gene Editing Therapy
Bo Yan, Beam Therapeutics
LC-MS/MS as a Potency Assay for mRNA Vaccines
Aline Dörrbaum, BioNTech SE
Proteomic Approaches for Characterization of Live Biotherapeutic Escherichia coli Nissle Products from Fermentation to Therapeutic Activity
Steven Bruckbauer, Synlogic Operating Company
Session Chairs
Related Products
The Regulator Panel: Can We Talk?
Featured Panelists:
Featured Joint Keynote Presentation: Hacking Structural Biology for Drug Delivery Using Protein Footprinting Based Mass Spectrometry
Joint Keynote Presenter Mark R. Chance Has a Message for You [https://www.youtube…
Keynote Session I: Quantitative Proteomics for Understanding Histone Mutations in Human Disease
Quantitative Proteomics for Understanding Histone Mutations in Human Disease (45 minutes)
